Alter Pharma Group
http://alterpharmagroup.be/
Already a Biomedtracker subscriber?
You have access to the full company record through your subscription
Want to become a subscriber?
Subscribers get more company details, updates, company financials and company products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Alter Pharma Group
Alter Pharma Group Rebrands As A.forall
Alter Pharma Group – including its US generics operation Milla Pharmacuticals, focused on niche injectables and solutions – has rebranded as A.forall.
Hyloris On Track To Meet 2024 Target During Half-Year Update
Hyloris CEO Stijn Van Rompay said the firm is on track to meet its target of 30 portfolio products by 2024, delivering a confident Q2 half-year update despite some pushback from the US Food and Drug Administration on its Maxigesic IV compound.
Company Information
- Industry
- Pharmaceuticals
- Services
-
Pharmaceuticals
- Generic Drugs
- OTC, Consumer
- Other Names / Subsidiaries
-
- CAP ALTER PHARMA, INC.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Alter Pharma Group
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice